Publicaciones en las que colabora con José Augusto García-Agúndez Pérez-Coca (14)

2022

  1. Vitamin D Receptor and Binding Protein Gene Variants in Patients with Essential Tremor

    Molecular Neurobiology, Vol. 59, Núm. 6, pp. 3458-3466

2017

  1. Delta-amino-levulinic acid dehydratase gene and essential tremor

    European Journal of Clinical Investigation, Vol. 47, Núm. 5, pp. 348-356

2015

  1. Heme Oxygenase 1 and 2 Common Genetic Variants and Risk for Essential Tremor

    Medicine, Vol. 94, Núm. 24, pp. e968

2013

  1. No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population

    Pharmacogenetics and Genomics, Vol. 23, Núm. 11, pp. 587-590

2012

  1. H1-MAPT and the risk for familial essential tremor

    PLoS ONE, Vol. 7, Núm. 7

2011

  1. Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor

    Journal of Neurology, Vol. 258, Núm. 2, pp. 203-211

  2. Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor

    Pharmacogenetics and Genomics, Vol. 21, Núm. 7, pp. 436-439

2010

  1. Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor

    European Journal of Neurology, Vol. 17, Núm. 6, pp. 879-881

2009

  1. Dopamine Receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor

    Movement Disorders, Vol. 24, Núm. 13, pp. 1910-1915

2008

  1. Glutathione-S-transferase P1 polymorphism and risk for essential tremor

    European Journal of Neurology, Vol. 15, Núm. 3, pp. 234-238

  2. The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor

    NeuroMolecular Medicine, Vol. 10, Núm. 4, pp. 356-361

2007

  1. Alcohol dehydrogenase 2 genotype and allelic variants are not associated with the risk for essential tremor

    Clinical Neuropharmacology, Vol. 30, Núm. 4, pp. 196-200

  2. Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor

    NeuroMolecular Medicine, Vol. 9, Núm. 2, pp. 195-204

2006

  1. CYP2C19 polymorphism and risk for essential tremor

    European Neurology, Vol. 56, Núm. 2, pp. 119-123